亚太：中国市场供应过剩和定价承压影响了中国区品牌制剂与工业品业务销售额，而差异化产品对 品牌制剂销售贡献显著。 占公司营业收入或营业利润 10%以上的行业、产品或地区情况 营业费用包含销售费用、管理费用以及研发投入。 （1）与 2017 年中国化工集团收购先正达相关的转移资产账面价值增加部分的摊销（非现金）：公司 剥离数款作物保护产品（此项剥离与此前欧盟委员会批准中国化工集团收购先正达事宜相关）而获得的 实收款项扣除税款及交易相关费用后的净额支付给先正达，以换取先正达在欧洲具有近似特质及经济价 值的一系列产品。由于从先正达收购的产品与剥离产品具有近似的特质和经济价值净额，本次产品剥离 与转移从经营层面而言不会对公司构成影响。上述摊销费用将持续到 2032 年，并随时间推移逐步减少， 但在 2028 年之前实际金额仍然较大；（2）收购交易的收购价格分摊产生的无形资产摊销（非现金性，不 影响被收购公司的经营业绩）；以及（3）与股价挂钩的激励计划相关影响。 剔除上述非经营性费用的影响，2023 年第二季度和上半年营业费用同比下降的主要原因包括：公司 采取多项费用管理措施，调整与业绩表现挂钩的员工薪酬拨备，以及汇率走 ...

Financial Performance - Revenue for 2022 reached 37.38 billion yuan, a year-on-year increase of 20.44%[3] - Net profit attributable to shareholders of the listed company was 609.39 million yuan, a year-on-year increase of 287.17%[3] - Total assets at the end of 2022 were 57.98 billion yuan, an increase of 15.42% compared to the previous year[3] - The company's financial expense net amount for 2022 was 1.83 billion yuan, an increase from 1.34 billion yuan in 2021[5] - The company's sales in Q4 2022 were $1,311.992 million, a decrease of 1.9% compared to the same period in 2021[60] - Pretax profit in Q4 2022 was a loss of $20.383 million, a significant decrease of 143.6% year-over-year[60] - Net profit in Q4 2022 was a loss of $22.425 million, a sharp decline of 189.0% compared to the same period in 2021[60] - EBITDA in Q4 2022 was $126.520 million, a decrease of 32.7% year-over-year[60] - The company's pretax profit margin in Q4 2022 was -1.6%, compared to 3.5% in the same period in 2021[60] - The company's net profit margin in Q4 2022 was -1.7%, compared to 1.9% in the same period in 2021[60] - The company's revenue for the four quarters of 2022 were 9,015,991 thousand yuan, 9,779,837 thousand yuan, 9,281,986 thousand yuan, and 9,304,101 thousand yuan respectively[80] - The company's net profit attributable to shareholders for the four quarters of 2022 were 427,652 thousand yuan, 304,446 thousand yuan, 36,046 thousand yuan, and -158,753 thousand yuan respectively[80] - The company's net cash flow from operating activities for the four quarters of 2022 were -1,813,846 thousand yuan, 467,985 thousand yuan, -212,839 thousand yuan, and 2,499,445 thousand yuan respectively[80] - Operating cash flow decreased significantly by 79.38% to 940,745 thousand yuan in 2022, compared to 4,561,875 thousand yuan in 2021[93] - Investment cash flow increased by 235.56% to 136,738 thousand yuan in 2022, while financing cash flow decreased by 18.59% to 4,632,633 thousand yuan[93] - Fair value changes due to exchange rate fluctuations resulted in a loss of 1,504,832 thousand yuan, accounting for -198.83% of total profit[95] - Asset impairment losses amounted to 325,386 thousand yuan, representing 42.99% of total profit[95] - Total revenue in 2022 reached 5,569,989 thousand RMB, a 15.7% year-on-year increase[124] - Herbicide sales grew by 25.7% to 2,478,957 thousand RMB, accounting for 44.5% of total revenue[124] - Latin America sales increased by 24.8% to 1,592,287 thousand RMB, driven by price increases and new product launches[126] - Asia-Pacific sales surged by 29.9% to 1,166,262 thousand RMB, with strong growth in China's fine chemical business[127] - Direct sales grew by 46.0% to 296,880 thousand RMB, representing 5.3% of total revenue[124] - Sales volume increased by 8% to 690,015 tons, while production volume rose by 6% to 529,135 tons[131] - R&D expenses increased by 15.25% to 577,859 thousand RMB, reflecting continued investment in innovation[135] - Financial expenses decreased by 83.20% to 325,796 thousand RMB, primarily due to reduced interest expenses[135] - Sales in Europe grew by 4.0% to 1,115,384 thousand RMB, with double-digit growth excluding Ukraine[124] - Canada saw strong growth across all product categories, supported by increased production capacity[125] - The company's subsidiary, Adama Solutions, reported revenues of RMB 48,124,396 thousand, with a net profit of RMB 15,019 thousand[190] Product and Market Performance - The company's main products include herbicides, insecticides, and fungicides, with herbicides being the most popular in markets such as soybeans, corn, grains, rice, and cotton[38] - The company's product portfolio includes over 300 active ingredients and 1,650 formulated products and formulations[117] - The company holds a 6.5% global market share in the non-patented crop protection market in 2022, up from 6.0% in 2021[112] - The company has obtained approximately 1,300 new product registrations over the past three years, supported by a global registration system capable of completing local registrations in over 100 countries and regions[112] - The global crop protection market is dominated by seven major multinational companies, including the group, with five being originator companies[192] - The group's global market share in 2022 was approximately 6.5%, up from 6% in 2021[192] - The European market accounts for about 22% of the group's sales, making the long-term trend of the Euro a significant factor affecting the group's performance[198] - The group faces significant currency risk exposure from the Euro, Israeli Shekel, and Brazilian Real, with other currencies posing smaller risks[198] - The group hedges most of its balance sheet exposures but only partially hedges economic exposures, leaving performance and profitability vulnerable to currency fluctuations[198] - Sales are directly influenced by agricultural seasonality, with peak sales in the Northern Hemisphere occurring in the first half of the year, primarily exposing the group to Euro risk[198] - In the Southern Hemisphere, peak sales occur in the second half of the year, primarily exposing the group to Brazilian Real risk[198] Costs and Expenses - The company's logistics, procurement, and production costs increased year-on-year in 2022, but gross profit grew due to significant price increases and volume growth[23] - The company's cost environment has improved since the second half of 2022, with raw material and logistics costs in China decreasing, although overall costs remain higher than pre-2020 levels[25] - The company's main raw material, active ingredients, accounted for 38.9% of total procurement, with an average price of $75.62/kg in the first half of the year and $72.87/kg in the second half[51] - Energy procurement costs accounted for over 30% of total production costs[51] - Raw material costs account for the highest proportion of the company's operating costs, mainly influenced by global supply and demand changes and international oil price fluctuations[74] - The company's supplier network has remained stable in recent years, with Chinese suppliers being the main source of raw materials due to their competitive prices and improving product quality[74] R&D and Innovation - The company is developing multiple R&D projects, including fungicides, herbicides, and insecticides, to expand its product pipeline[6] - R&D personnel increased by 5.32% to 277 in 2022, with the proportion of R&D personnel rising to 3.01% from 2.86% in 2021[92] - R&D expenses increased by 15.25% to 577,859 thousand RMB, reflecting continued investment in innovation[135] Operations and Production - The company operates in over 100 countries through approximately 60 subsidiaries, focusing on non-patented crop protection products[36] - The company operates in major chemical parks in Israel, China, and Brazil, producing various pesticides, herbicides, and fine chemical products[53] - The company's production facilities include dedicated facilities for specific products and multi-purpose facilities for various products, with multi-purpose facilities being the main body of the production system[74] - The company's supply chain typically includes importers/formulators, distributors, retailers, and farmers, with the company often acting as importers and/or formulators, and sometimes as distributors or retailers[74] - Herbicide production capacity utilization reached 79%, with an additional 13,000 tons/year under construction[107] - Fungicide production capacity utilization was 68%, with 5,500 tons/year under construction[107] - Insecticide production capacity utilization stood at 54%, with 5,500 tons/year under construction[107] - The company restructured its India, Middle East, and Africa region into the Europe, Africa, and Middle East region starting in 2023[101] Financial Instruments and Hedging - The company's derivative investments totaled 2.64 billion yuan, accounting for 113.97% of the net assets at the end of the reporting period[2] - The company's financial assets totaled 393,835 thousand yuan at the end of the period, with a decrease of 1,200,368 thousand yuan in fair value changes during the period[24] - The company's financial liabilities increased to 545,516 thousand yuan at the end of the period, with a fair value change gain of 369,310 thousand yuan during the period[24] - The company's financial expenses (pre-hedging) for 2022 were 326 million yuan (43 million USD), compared to 1.939 billion yuan (301 million USD) in 2021[47] - The impact of hedging transactions on fair value changes resulted in a net loss of 1.505 billion yuan (230 million USD) in 2022, compared to a net gain of 598 million yuan (93 million USD) in 2021[47] - The company uses derivative financial instruments to hedge against exchange rate and inflation risks related to financial assets and liabilities. The fair value changes of these derivatives are included in the fair value change gains and losses[160] - The group uses derivative financial instruments to hedge against foreign exchange and inflation risks, with the fair value of these instruments determined based on financial institution quotes[200] - Changes in assumptions and calculation models for derivative financial instruments could lead to significant changes in their fair value and operating results[200] Dividends and Shareholder Information - The company plans to distribute a cash dividend of 0.27 yuan per 10 shares for the 2022 fiscal year[8] - The company's controlling shareholder remained unchanged during the reporting period, with Syngenta Group Co., Ltd. being the controlling shareholder since June 2020[87] Taxation and Regulatory Compliance - The company holds multiple licenses, including safety production permits, pesticide business licenses, and pollution discharge permits, with validities ranging from 2023 to 2028[55] - The company holds various production, transportation, and sales licenses, including pesticide production licenses, safety production licenses, and hazardous chemical operation licenses, with validity periods ranging from 2023 to 2027[110] - The company's major subsidiaries and their tax rates include ADAMA Agricultural Solutions Ltd. in Israel at 23.0%, ADAMA Brasil S/A in Brazil at 34.0%, and ADAMA India Private Ltd. in India at 25.2%[174] - The company enjoys a 15% corporate income tax rate as a high-tech enterprise from 2020 to 2022, approved by the Hubei Provincial Science and Technology Department, Hubei Provincial Finance Department, and Hubei Provincial Taxation Bureau[175] - The subsidiary, Adama Anbang (Jiangsu) Co., Ltd., also benefits from a 15% corporate income tax rate as a high-tech enterprise from 2021 to 2023[175] - The company's industrial subsidiaries in Israel are granted "Approved Enterprise" or "Beneficiary Enterprise" status, allowing for tax benefits under the Capital Investment Encouragement Law (1959)[175] - Priority companies in Israel enjoy a reduced tax rate of 7.5% for income generated in Development Zone A, while other regions have a 16% rate[175] - Special priority technology enterprises in Israel benefit from a 6% tax rate, regardless of location[175] Asset and Liability Management - The company's total monetary funds as of December 31, 2022, amounted to RMB 4,290,961 thousand, with RMB 3,300,538 thousand held overseas[176] - The company's cash and cash equivalents decreased from RMB 5,818,835 thousand in 2021 to RMB 4,290,961 thousand in 2022[176] - The company's fixed assets are derecognized when they are disposed of or when they are no longer expected to generate economic benefits through use or disposal. The difference between the disposal proceeds and the carrying amount, net of related taxes, is recognized in the current period's profit or loss[150] - The company determines whether right-of-use assets have been impaired and accounts for them in accordance with the relevant provisions of Accounting Standards for Business Enterprises No. 8 - Asset Impairment[151] - Changes in the fair value of non-hedging derivative financial instruments are included in the fair value change gains and losses[152] - The company recognizes short-term employee benefits as liabilities during the period in which the employees provide services. When the company has a legal or constructive obligation to pay monetary bonuses for past services, and the amount can be reliably estimated, it is recognized as a liability[155] - The recoverable amount of construction in progress that is lower than its carrying amount is recognized as an impairment loss[158] - The company's long-term post-employment benefits and other long-term benefit liabilities are calculated based on the expected future payments to employees. These liabilities are presented net of plan assets and discounted, and changes in actuarial assumptions can significantly impact the liabilities and operating results[173] Customer and Supplier Information - The top five customers accounted for 8.35% of the total annual sales, with related party sales accounting for 4.32%[15] - The company's customers are distributed worldwide, with sales typically made to regional distributors who then sell to end customers, including large agricultural cooperatives[74] - Top 5 suppliers accounted for 18.58% of total annual procurement, with the largest supplier contributing 5.47%[99] Non-Recurring Items - The company's non-recurring gains and losses for 2022 amounted to 118,963 thousand yuan, compared to 79,544 thousand yuan in 2021 and 65,029 thousand yuan in 2020[79] Overseas Operations - The company's overseas assets accounted for 86% of its net assets, with no significant impairment risk[16] - The company operates through approximately 60 subsidiaries worldwide, adhering to local tax policies[112]

证券代码：000553（200553） 证券简称：安道麦 A/安道麦 B 安道麦股份有限公司投资者关系活动记录表 编号：2020-03 | --- | --- | --- | |-----------------------------|------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 投资者关系 活动类别 | □ \n□ 媒体采访 业绩说明会 \n□新闻发布 ...

证券代码：000553（200553） 证券简称：安道麦 A/安道麦 B 安道麦股份有限公司投资者关系活动记录表 编号：2020-01 | --- | --- | --- | |-----------------------------|-----------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | □ | 特定对象调研 分析师会议 | | | □ | 媒体采访 □业绩说明会 | | 投资者关系 活动类别 | □ 现场参观 | □新闻发布会 □路演活动 | ...

证券代码：000553（200553） 证券简称：安道麦 A/安道麦 B 编号：2020-02 | --- | --- | --- | |-----------------------------|----------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 投资者关系 活动类别 | □ \n□ \n□ ...

证券代码：000553（200553） 证券简称：安道麦 A/安道麦 B 安道麦股份有限公司投资者关系活动记录表 编号：2020-04 | --- | --- | --- | |-----------------------------|----------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：000553（200553） 证券简称：安道麦 A/安道麦 B 编号：2020-05 | --- | --- | --- | |-----------------------------|--------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...